Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 2, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Down Syndrome
Interventions
OTHER

No Intervention

No intervention was administered in this study

Trial Locations (10)

15706

Complejo Hospitalario Universitario de Santiago (CHUS); Area Asistencial Integrada de Pediatría, Santiago de Compostela

27710

Duke Clin Rsch Institute, Durham

28009

Hospital Infantil Universitario Niño Jesus; Pediatria Social, Madrid

33076

CHU de Bordeaux Hopital Pellegrin; Service de Genetique Medicale, Bordeaux

34295

CHU de Montpellier Hopital Arnaud de Villeneuve; de Génétique, Montpellier

42055

CHU de Saint Etienne; Service de Génétique, Saint-Etienne

69003

Groupement Hospitalier Est-Hopital Femme Mere enfant/Hospice civils de lyon, Bron

85724-5030

University of Arizona, Tucson

02114

Massachusetts General Hospital, Boston

08009

IMIM, Human Pharmacology and Clinical Neurosciences,, Barcelona

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02451657 - Non-drug Study to Evaluate the Suitability of Neurocognitive Tests and Functioning Scales for the Measurement of Cognitive and Functioning Changes in Children With Down Syndrome | Biotech Hunter | Biotech Hunter